Abdul-Ghani, M A <br/><br/>
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Mar 2015 
 - 268-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12417  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus, Type 2--complications<br/>Drug Therapy, Combination--methods<br/>Exenatide<br/>Female<br/>Glycated Hemoglobin--drug effects<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin Resistance<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Peptides--therapeutic use<br/>Pioglitazone<br/>Thiazolidinediones--therapeutic use<br/>Venoms--therapeutic use<br/>Weight Gain--drug effects<br/>Weight Loss--drug effects